바이오테크 보도자료
-
- KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
- KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb ™, an offering built on the robustness of KBI’s SUREtechnology Platform™, that allows for optimized, safe, and co...
- 2023년 09월 13일
-
- Monrol Announces Investment to Expand its n.c.a. Lu-177 Production Capacity
- Eczacıbaşı Monrol Nuclear Products Co. (Monrol), one of the world’s leading radiopharmaceutical producers, has decided to invest 35 million Euros to increase its production capacity for non-carrier-added Lut...
- 2023년 09월 12일
-
- SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
- Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company has completed the phase I clinical trial for its broad-s...
- 2023년 09월 12일
-
- Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis
- Takeda (TSE:4502/NYSE:TAK ) today announced positive topline results from its randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial evaluating TAK-279, an investigational oral allosteric...
- 2023년 09월 12일
-
- Yokogawa to Supply Energy Management System for Yuri Green Hydrogen Project in Australia
- Yokogawa Electric Corporation (TOKYO: 6841) announces that its subsidiary Yokogawa Australia has received an order from Monford Group Pty Ltd. to supply an energy management system (EMS) for the initial phas...
- 2023년 09월 11일
-
- Biocytogen Enters into Antibody Evaluation, Option and License Agreement with Myricx for ADC Development
- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today announces an antibody evaluation, option a...
- 2023년 09월 08일
-
- Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that its Board of Directors (the “Board of Directors”) unanimously ...
- 2023년 09월 06일
-
- Organon Bolsters Research & Development Expertise with Two Leadership Appointments
- Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced the appointment of Juan Camilo Arjona Ferreira, M.D., as Chief Medical Officer (CMO) and Charlotte Owens, M.D....
- 2023년 09월 06일
-
- LabGenomics USA LLC Acquires QDx Pathology in a Strategic Move to Expand its Diagnostic Lab Services and IVD Diagnostic Products Business into the US Market
- LabGenomics USA, a subsidiary of LabGenomics Co., Ltd., announced its acquisition of QDx Pathology, a leader in molecular and diagnostic pathology. The acquisition is expected to have significant implication...
- 2023년 09월 06일
전시회
